We are live on ! Find out more

528 hedge funds and large institutions have $7.35B invested in Chemed in 2024 Q4 according to their latest regulatory filings, with 63 funds opening new positions, 163 increasing their positions, 213 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more call options, than puts

Call options by funds: $14.3M | Put options by funds: $3.39M

11% more first-time investments, than exits

New positions opened: 63 | Existing positions closed: 57

0% more funds holding

Funds holding: 527528 (+1)

1.39% less ownership

Funds ownership: 94.07%92.67% (-1.4%)

13% less capital invested

Capital invested by funds: $8.46B → $7.35B (-$1.11B)

23% less repeat investments, than reductions

Existing positions increased: 163 | Existing positions reduced: 213

60% less funds holding in top 10

Funds holding in top 10: 52 (-3)

Holders
528
Holders Change
+1
Holders Change %
+0.19%
% of All Funds
6.95%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
63
Increased
163
Reduced
213
Closed
57
Calls
$14.3M
Puts
$3.39M
Net Calls
+$10.9M
Net Calls Change
+$10.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Goldman Sachs
51
Goldman Sachs
New York
$25.3M -$14.5M -25,707 -35%
Renaissance Technologies
52
Renaissance Technologies
New York
$25M -$369K -654 -1%
Allspring Global Investments
53
Allspring Global Investments
North Carolina
$24.3M +$2.13M +3,785 +9%
Schroder Investment Management Group
54
Schroder Investment Management Group
United Kingdom
$23.9M +$261K +463 +1%
UBS Group
55
UBS Group
Switzerland
$23.5M +$7.35M +13,036 +42%
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
$23.1M +$17.5K +31 +0.1%
Retirement Systems of Alabama
57
Retirement Systems of Alabama
Alabama
$22.3M -$36.1K -64 -0.2%
FWIA
58
Fort Washington Investment Advisors
Ohio
$21.7M +$6.21M +11,020 +37%
ACA
59
Aptus Capital Advisors
Alabama
$21.6M +$4.13M +7,327 +22%
N
60
Nuveen
North Carolina
$20.9M +$3.39M +6,005 +18%
Amundi
61
Amundi
France
$20.1M -$6.39M -11,340 -23%
Fuller & Thaler Asset Management
62
Fuller & Thaler Asset Management
California
$19.7M -$4.38M -7,765 -17%
Squarepoint
63
Squarepoint
New York
$19.3M -$3.1M -5,506 -13%
Loomis, Sayles & Company
64
Loomis, Sayles & Company
Massachusetts
$19.3M +$4.12M +7,303 +25%
SEI Investments
65
SEI Investments
Pennsylvania
$18.4M -$2.32M -4,115 -11%
MWM
66
Moran Wealth Management
Florida
$18M +$11.3K +20 +0.1%
First Trust Advisors
67
First Trust Advisors
Illinois
$17.7M -$532K -943 -3%
AA
68
ALPS Advisors
Colorado
$16.8M +$2.01M +3,558 +13%
Legal & General Group
69
Legal & General Group
United Kingdom
$16.7M -$1.23M -2,188 -6%
Man Group
70
Man Group
United Kingdom
$16.2M -$1.19M -2,111 -6%
Pictet Asset Management
71
Pictet Asset Management
Switzerland
$15.7M -$5.26M -9,330 -24%
FAM
72
Fenimore Asset Management
New York
$15.4M +$1.11M +1,968 +7%
MAM
73
Martingale Asset Management
Massachusetts
$14.9M -$2.18M -3,861 -12%
Swiss National Bank
74
Swiss National Bank
Switzerland
$14.9M
AAM
75
Aureus Asset Management
Massachusetts
$14.8M -$1.1M -1,955 -7%

CHE Hedge Fund Activity: Q4 2024 in Review

528 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q4 2024, worth a combined $7.35B — down 13% from $8.46B a quarter earlier.

Buyers outnumbered sellers: 63 funds opened new CHE positions and 57 closed out — a net gain of 6 holders — while 163 added to existing stakes and 213 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $58.1M. The largest seller was TimesSquare Capital Management, cutting an estimated $90.7M.

  • 528 institutional investors held Chemed (CHE) as of Q4 2024, up from 527 in Q3 2024.
  • Funds reported $7.35B of Chemed stock for Q4 2024, down 13% quarter-over-quarter.
  • 63 funds opened new Chemed positions in Q4 2024 and 57 closed out, a net change of +6 holders.
  • The largest Chemed buyer in Q4 2024 was Point72 Asset Management, an estimated $58.1M added.
  • The largest Chemed seller in Q4 2024 was TimesSquare Capital Management, an estimated $90.7M sold.

Based on aggregated 13F filings for Q4 2024.